Member Info for Soupdragon78

Halespur, just re-reading the rns and it makes the same comment on NXP001 about it being successful in humans. Seems odd they need to mention this. So I’m warming to my guess that they have seen other ‘non-human’ markets for it.

Haven’t got a clue how that would pan out but just a thought.

“Having demonstrated the successful application of our proprietary cocrystal technology in humans using NXP001, we believe this product could also be of interest to third parties. Whilst it is too early to characterise this, we will be extending our business development efforts in this area over the coming 12 months. This will be greatly assisted by our network of key opinion leaders and scientific advisors”

Halespur, on the NXP001 vetenerinary side, it’s purely me guessing. In the interview Blackwell uses an interesting turn of phrase (see 5min 20sec onwards).

He talks about them demonstrating cocrystal tech success ‘we’ve done this in humans. This product could also be of interest to other third parties, it’s a little too early to characterise what I mean by that.’

May be nothing It just seemed an odd thing to highlight then say he can’t characterise it.

Halespur, my disappointment is that Ebers is a signed £51m contract, the biggest done by the company. Yet in today’s finals under ‘operating highlights’ it doesn’t even get a single line of it’s own! If the highlight of the past year is not signing this then what is it? (Question directed at company not personally at you)

In terms of performance, obviously we don’t get to see the contract but we can piece together from the previous announcements.

From the original rns last April

“it will earn further R&D and early-stage milestone payments up to a total of GBP1m during 2019”

Fair enough NFX got £535k in this period to end of 2019 so a bit short on expectation.

Then from the patent rns.

“The number of patents filed is one of several key performance indicators for the collaboration and demonstrates the partnership and overall concept are well-founded.”

From interims in December

“First patent filed from the collaboration and progress remains on track to deliver further milestones within the current financial year”

So again didn’t manage to succeed in achieving the KPI’s or what they set out in their interims.

Quite happy for them to say it’s taking longer. I just don’t want them to do what they did with NXP003 and silently drop it.

Quite clear now that DG resigned as he failed in the negotiations, remember they said they were talking to a US company which has now been dropped.

Also that they failed to meet their KPI’s on Ebers and only filed one patent in the year. As I’ve previously mentioned I was concerned about this, and also worried now that it’s almost none existent in today’s rns, despite being their biggest deal to date.

Halespur, good post.

It’s interesting in both the rns and video, Blackwell talks about developing their own product. Either he’s confident of being able to cover cost on this through income, or other means of funding.

Also the video alludes to NXP001 moving into the veterinary markets.

Whimax, would you still go on about how good it could be once it got fixed? Or would your mates not get bored of that?

And you’d never mention the problem you had with it to anyone?

Whimax, if you spent a lot of money on a car and it broke down and took a long time to fix, would you say you were happy with it?

Nxp004 delay is no surprise, I’ve pointed out this would be the case before. Although certain posters tried to say that NFRG were back onto it.

Exactly chablard. Although for me it shows the unreasonable expectations of shareholders. People here forget that NFX only have two people doing the science. Given they were already working on a number of research items, they can’t easily jump onto something new.

Silverpixel, it is possible to have investments in more than one company at a time you know.

Cash position is fine, plus they have had two milestone payments since year end. Slightly annoyed they didn’t disclose these.

Anyone pointing to the £4K cash figure is deliberately trying to add a negative and needs to learn how to read a balance sheet. That was the cash figure at April 2019.

Thanks for flagging up the changes olderbutwiser.

Also Thillai added to advisors page (finally)

Interesting update. A few glimpses of further developments both positive and slightly negative.

Olderbutwiser, apologies, I din't realise you couldn't see older trades.

Example below of the 500k at 4.2p. As you'll see for a good ten mins before all the buys were at 4.3p, even a 250k at 4.29p. Same pattern for the other 500k's, all buys for ten mins before were higher.

20-Jul-20 10:37:52 4.22 38,970 Sell* 4.20 4.30 1,645 O
20-Jul-20 10:37:45 4.20 500,000 Sell* 4.20 4.30 21.00k O
20-Jul-20 10:37:17 4.22 12,655 Sell* 4.20 4.30 534.04 O
20-Jul-20 10:35:19 4.30 65,000 Buy* 4.10 4.30 2,795 O
20-Jul-20 10:34:51 4.30 9,024 Buy* 4.10 4.30 388.03 O
20-Jul-20 10:34:07 4.30 7,843 Buy* 4.10 4.30 337.25 O
20-Jul-20 10:32:59 4.30 5,484 Buy* 4.10 4.30 235.81 O
20-Jul-20 10:32:58 4.152 25,038 Sell* 4.10 4.30 1,040 O
20-Jul-20 10:31:47 4.30 13,594 Buy* 4.10 4.30 584.54 O
20-Jul-20 10:31:14 4.30 22,863 Buy* 4.10 4.30 983.11 O
20-Jul-20 10:30:50 4.30 15,000 Buy* 4.10 4.30 645.00 O
20-Jul-20 10:30:49 4.30 20,000 Buy* 4.10 4.30 860.00 O
20-Jul-20 10:29:03 4.30 50,000 Buy* 4.10 4.30 2,150 O
20-Jul-20 10:28:44 4.30 69,767 Buy* 4.10 4.30 3,000 O
20-Jul-20 10:28:33 4.30 4,306 Buy* 4.10 4.30 185.16 O
20-Jul-20 10:28:00 4.29 50,000 Buy* 4.10 4.30 2,145 O
20-Jul-20 10:27:55 4.29 23,310 Buy* 4.10 4.30 1,000.00 O
20-Jul-20 10:27:46 4.29 11,597 Buy* 4.10 4.30 497.51 O
20-Jul-20 10:27:11 4.29 259,571

Olderbutwiser, just use the nfx trades button here on LSE. You’ll see the trades either side of the 500k’s all buys were above the price at the time. The big trades were easily sells into strength.

If you buy that amount you pay a premium, you don’t get a discount to the prevailing price.

It’s the correction to show the average sell price from the corresponding sell trades yesterday.

There were 3 x 500k trades ( at 4p, 4.125p & 4.2p) not sure which 100k is related.

These are then cancelled and the aggregate trade posted, 1.6m at 4.125p.

Happens quite a lot on NFX.

Interesting change in dynamic this afternoon. 200k buys seeming frequent now.

Yep, they said they would communicate the date when they would release finals. But unsurprisingly have failed to do so.

“Looking ahead; in July, we will be announcing Preliminary Results for the period year ended 31 March 2020, and a date will be set for this and communicated in due course.”

With regards to company cash.

Firstly, just wait till prelims are out this month (unless they use the Covid delay for an extra two months).

Secondly, they have a contract for up to £51m in payments till the end of 2021.